Statement of Retraction: Clinical practice of epidermal growth factor receptor-tyrosine kinase inhibitor targeted drugs combined with gadolinium oxide nanoparticles in the treatment of non-small cell lung cancer
2024
Retraction of Study on Lung Cancer Treatment
publication
Author Information
Author(s): Xuan Zhou, Ting Jin, Likun Wang, Erlin Zhao, Xuyang Xiao
Conclusion
The article was retracted due to significant concerns about the integrity of the data and reported results.
Supporting Evidence
- The authors did not provide their original data or any necessary supporting information.
- The integrity of the scholarly record is essential, leading to the retraction.
Takeaway
The study on a lung cancer treatment was taken back because the authors couldn't prove their results were correct.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website